CervoMed, Inc. (CRVO)
2.44
+0.01
(+0.41%)
USD |
NASDAQ |
Sep 21, 16:00
2.44
0.00 (0.00%)
After-Hours: 20:00
CervoMed Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -1.103 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0018 |
| June 30, 2021 | 0.0019 |
| March 31, 2021 | 0.0022 |
| December 31, 2020 | 0.006 |
| September 30, 2020 | 0.0061 |
| June 30, 2020 | 0.0059 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0125 |
| December 31, 2019 | 0.0123 |
| September 30, 2019 | 0.0199 |
| June 30, 2019 | 0.018 |
| March 31, 2019 | 0.0242 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0185 |
| December 31, 2017 | 0.0259 |
| September 30, 2017 | 0.0865 |
| June 30, 2017 | 2.081 |
| March 31, 2017 | -0.1271 |
| December 31, 2016 | 0.2646 |
| September 30, 2016 | 0.2116 |
| June 30, 2016 | 0.0392 |
| March 31, 2016 | 0.0332 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.0058 |
| June 30, 2014 | 0.0202 |
| March 31, 2014 | 0.2528 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 25.99M |
| Total Liabilities (Quarterly) | 3.032M |
| Shareholders Equity (Quarterly) | 22.96M |
| Current Ratio | 8.466 |